Skip to main content


Link: I'm a Buyer of Bristol Myers in Low $30s

Stephanie Link, director of research at TheStreet, says the move in Bristol Myers' stock from the suspension of a Hepatitis C compound has been overdone and sees value in the stock.

Morning Briefing: 10 Things You Should Know

U.S. stock futures lower; 3M, Exxon and United Technologies report earnings; Facebook posts its first report as a public company.

Market Preview: Facebook's Folly

The company sold so much stock in its IPO, and at such a high valuation, the shares still seem to have nowhere to go but down.

Eli Lilly, Verastem and the Defenders of Shareholder Value

TheStreet contributor Nate Sadeghi calls for healthcare investors to start acting like owners.

Obamacare vs. the Stock Market

Stephanie Link, director of research at TheStreet, tells us how to invest in health care given the Obamacare overhang.

Breaking News

Elon Musk and Tesla Set Their Sights on a Popular Industry

The electric vehicle manufacturer has a very popular industry in its sights despite often low margins.

New Trader Joe's Popcorn Just Dropped

Here's why people are freaking out about the latest Trader treat.

Tank Tips: Best Gas Saving Moves for Memorial Day

Cut costs with these Memorial Day gasoline-saving tips

Luxury-Home Builder Toll Brothers Beats Q2 Profit, Revenue Estimates

Toll Brothers earned $1.85 a share in its fiscal second quarter on 18% higher revenue.